The treatment, CYT387, appears to demonstrate an ability to render and maintain myelofibrosis patients transfusion independent for clinically-relevant periods, while also improving other symptoms, according to a phase I and phase II study.

FORBES: Pharma News: Alexza Pharmaceuticals, YM BioSciences

Another key feature is a comparison recommendation engine for health plans that people can use during their open enrollment periods or when choosing an independent health plan.

FORBES: TechCrunch Disrupt Roundup: CakeHealth, Farmigo, Shaker

Plausible deniability notwithstanding, as independent business owners we all have these feast-or-famine periods.

FORBES: Assessing Time Management Issues: A Healthy Gut-Check for the Small Business Owner